A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...
A new clinical trial is enrolling up to 60 children and young people with solid tumors across the United States and United ...
Poster Presentation to Spotlight Ongoing Phase 1 Clinical Trial of EVOLVE104Oral and Poster Presentations to Highlight Preclinical Data ...
CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...
A single-center real-world study compares the effectiveness and toxicity of chimeric antigen receptor T-cell therapy vs ...
Researchers built an immune-aging clock from 1.2 million cells, revealing T cells as key indicators of immune aging. They ...
New Scientist on MSN
CAR T-cell therapy takes woman from bedridden to 'perfectly fine'
A woman with three different autoimmune conditions had all of them treated simultaneously by genetically modifying her immune ...
The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...
Scientists have discovered how two transcription factors form a reciprocal regulatory circuit that controls T-cell exhaustion ...
Chimeric antigen receptor T-cell therapy (CAR T) has revolutionized oncology treatment over the last decade, offering targeted therapy options for several difficult cancers, espec ...
Title: A novel and versatile Prodrug T cell engager platform with a novel candidate demonstrating potent and tumor-restricted activity Presentation Time: 9:00AM - 12:00PM, local time (Location: Poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results